Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Candidates for transcatheter aortic valve replacement: fitting the PARTNERS criteria.

Babcock MJ, Lavine S, Strom JA, Bass TA, Guzman LA.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):655-61. doi: 10.1002/ccd.24706. Epub 2013 Apr 5.

PMID:
23074160
2.

Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.

Nazif TM, Dizon JM, Hahn RT, Xu K, Babaliaros V, Douglas PS, El-Chami MF, Herrmann HC, Mack M, Makkar RR, Miller DC, Pichard A, Tuzcu EM, Szeto WY, Webb JG, Moses JW, Smith CR, Williams MR, Leon MB, Kodali SK; PARTNER Publications Office.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):60-9. doi: 10.1016/j.jcin.2014.07.022.

3.

Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).

Hahn RT, Pibarot P, Webb J, Rodes-Cabau J, Herrmann HC, Williams M, Makkar R, Szeto WY, Main ML, Thourani VH, Tuzcu EM, Kapadia S, Akin J, McAndrew T, Xu K, Leon MB, Kodali SK.

JACC Cardiovasc Interv. 2014 Jul;7(7):781-9. doi: 10.1016/j.jcin.2014.02.013.

4.

Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.

Martinez CA, Singh V, O'Neill BP, Alfonso CE, Bilsker MS, Martinez Clark P, Williams D, Cohen MG, Heldman AW, O'Neill WW.

Catheter Cardiovasc Interv. 2013 Aug 1;82(2):300-11. doi: 10.1002/ccd.24807. Epub 2013 Apr 11.

PMID:
23580318
5.

Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.

Jerez-Valero M, Urena M, Webb JG, Tamburino C, Munoz-Garcia AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Alonso Briales JH, Al Lawati H, Benitez LM, Cucalon AM, Garcia del Blanco B, Revilla A, Dumont E, Barbosa Ribeiro H, Nombela-Franco L, Bergeron S, Pibarot P, Rodés-Cabau J.

JACC Cardiovasc Interv. 2014 Sep;7(9):1022-32. doi: 10.1016/j.jcin.2014.04.012. Erratum in: JACC Cardiovasc Interv. 2014 Oct;7(10):1204.

6.

Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien(©) valves: a single center experience.

McCabe JM, Huang PH, Riedl LA, Devireddy SR, Grondell J, Connors AC, Davidson MJ, Eisenhauer AC, Welt FG.

Catheter Cardiovasc Interv. 2014 Mar 1;83(4):633-41. doi: 10.1002/ccd.25206. Epub 2013 Nov 13.

PMID:
24123706
7.

Futility, benefit, and transcatheter aortic valve replacement.

Lindman BR, Alexander KP, O'Gara PT, Afilalo J.

JACC Cardiovasc Interv. 2014 Jul;7(7):707-16. doi: 10.1016/j.jcin.2014.01.167. Epub 2014 Jun 18. Review.

8.

Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.

Fearon WF, Kodali S, Doshi D, Fischbein MP, Yeung AC, Tuzcu EM, Rihal CS, Babaliaros V, Zajarias A, Herrmann HC, Brown DL, Mack M, Teirstein PS, Whisenant BK, Makkar R, Kapadia S, Leon MB; PARTNER Trial Investigators.

JACC Cardiovasc Interv. 2014 Nov;7(11):1245-51. doi: 10.1016/j.jcin.2014.05.033. Epub 2014 Nov 17.

9.

Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.

Kamperidis V, van Rosendael PJ, de Weger A, Katsanos S, Regeer M, van der Kley F, Mertens B, Sianos G, Ajmone Marsan N, Bax JJ, Delgado V.

JACC Cardiovasc Interv. 2015 Apr 27;8(5):670-7. doi: 10.1016/j.jcin.2014.10.029.

10.

Dynamic characterization of aortic annulus geometry and morphology with multimodality imaging: predictive value for aortic regurgitation after transcatheter aortic valve replacement.

Masri A, Schoenhagen P, Svensson L, Kapadia SR, Griffin BP, Tuzcu EM, Desai MY.

J Thorac Cardiovasc Surg. 2014 Jun;147(6):1847-54. doi: 10.1016/j.jtcvs.2013.05.047. Epub 2013 Jul 16.

11.

Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement.

Spangenberg T, Budde U, Schewel D, Frerker C, Thielsen T, Kuck KH, Schäfer U.

JACC Cardiovasc Interv. 2015 Apr 27;8(5):692-700. doi: 10.1016/j.jcin.2015.02.008.

12.

Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.

Nombela-Franco L, del Trigo M, Morrison-Polo G, Veiga G, Jimenez-Quevedo P, Abdul-Jawad Altisent O, Campelo-Parada F, Biagioni C, Puri R, DeLarochellière R, Dumont E, Doyle D, Paradis JM, Quirós A, Almeria C, Gonzalo N, Nuñez-Gil I, Salinas P, Mohammadi S, Escaned J, Fernández-Ortiz A, Macaya C, Rodés-Cabau J.

JACC Cardiovasc Interv. 2015 Nov;8(13):1748-57. doi: 10.1016/j.jcin.2015.07.022.

13.

Cardiopulmonary bypass and intra-aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: a PARTNER trial substudy.

Shreenivas SS, Lilly SM, Szeto WY, Desai N, Anwaruddin S, Bavaria JE, Hudock KM, Thourani VH, Makkar R, Pichard A, Webb J, Dewey T, Kapadia S, Suri RM, Xu K, Leon MB, Herrmann HC.

Catheter Cardiovasc Interv. 2015 Aug;86(2):316-22. doi: 10.1002/ccd.25776. Epub 2015 Feb 3.

PMID:
25546704
14.

Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.

Shah AM, Ogbara J, Herrmann HC, Fox Z, Kadakia M, Anwaruddin S, Bavaria JE, Desai ND, Jagasia D, Szeto WY, Li RH, Vallabhajosyula P, Giri J.

Catheter Cardiovasc Interv. 2015 Nov;86(5):888-94. doi: 10.1002/ccd.25994. Epub 2015 May 11.

PMID:
25963625
15.

Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement.

Lardizabal JA, Macon CJ, O'Neill BP, Desai H, Singh V, Martinez CA, Alfonso CE, Cohen MG, Heldman AW, O'Neill WW, Williams DB.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1226-30. doi: 10.1002/ccd.25785. Epub 2015 Feb 3.

PMID:
25511236
16.

Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).

Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, Douglas PS, Mack M, McAndrew TC, Svensson L, Thourani VH, Tuzcu EM, Weissman NJ, Kirtane AJ, Leon MB.

J Am Coll Cardiol. 2014 Apr 22;63(15):1522-8. doi: 10.1016/j.jacc.2014.01.036. Epub 2014 Feb 19.

17.

Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience.

Cohen MG, Singh V, Martinez CA, O'Neill BP, Alfonso CE, Martinezclark PO, Heldman AW, O'Neill WW.

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):987-93. doi: 10.1002/ccd.25036. Epub 2013 Jul 3.

PMID:
23729031
18.

Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).

Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB.

J Am Coll Cardiol. 2014 Mar 25;63(11):1100-9. doi: 10.1016/j.jacc.2013.10.058. Epub 2013 Nov 27.

19.

Choice of Treatment for Aortic Valve Stenosis in the Era of Transcatheter Aortic Valve Replacement in Eastern Denmark (2005 to 2015).

De Backer O, Luk NH, Olsen NT, Olsen PS, Søndergaard L.

JACC Cardiovasc Interv. 2016 Jun 13;9(11):1152-8. doi: 10.1016/j.jcin.2016.02.028. Epub 2016 May 18.

20.

Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.

Dvir D, Sagie A, Porat E, Assali A, Shapira Y, Vaknin-Assa H, Shafir G, Bental T, Nevzorov R, Battler A, Kornowski R.

Catheter Cardiovasc Interv. 2013 Apr;81(5):871-81. doi: 10.1002/ccd.24623. Epub 2012 Sep 24.

PMID:
22915555

Supplemental Content

Support Center